Indirect comparison of TPF and GP induction chemotherapy regimens in nasopharyngeal carcinoma: a data-driven reassessment before the transition to induction chemoimmunotherapy.
作者信息
Cavalieri Stefano, Ottini Arianna, Lombardi Stocchetti Benedetta, Licitra Lisa
机构信息
Head and Neck Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, via Giacomo Venezian 1, 20133 Milan, Italy.
Department of Oncology and Hemato-oncology, University of Milan, via Santa Sofia 9/1, 20122 Milan, Italy.
出版信息
Oncologist. 2025 Jul 4;30(7). doi: 10.1093/oncolo/oyaf175.
Abstract
摘要
相似文献
1
Indirect comparison of TPF and GP induction chemotherapy regimens in nasopharyngeal carcinoma: a data-driven reassessment before the transition to induction chemoimmunotherapy.鼻咽癌中TPF与GP诱导化疗方案的间接比较：向诱导化疗免疫治疗过渡前的数据驱动再评估
Oncologist. 2025 Jul 4;30(7). doi: 10.1093/oncolo/oyaf175.
2
Comparison of TPF and PF induction chemotherapy combined with cisplatin concurrent chemoradiotherapy for locoregionally advanced nasopharyngeal carcinoma: A systematic review and meta-analysis.TPF与PF诱导化疗联合顺铂同步放化疗治疗局部晚期鼻咽癌的比较：一项系统评价和Meta分析
Medicine (Baltimore). 2025 Jan 17;104(3):e41278. doi: 10.1097/MD.0000000000041278.
3
Comparison of five cisplatin-based regimens frequently used as the first-line protocols in metastatic nasopharyngeal carcinoma.比较五种常用于转移性鼻咽癌一线方案的顺铂类方案。
J Cancer Res Clin Oncol. 2012 Oct;138(10):1717-25. doi: 10.1007/s00432-012-1219-x. Epub 2012 Jun 10.
4
Harnessing deep learning to optimize induction chemotherapy choices in nasopharyngeal carcinoma.利用深度学习优化鼻咽癌诱导化疗方案的选择
Radiother Oncol. 2025 Jul 28;211:111047. doi: 10.1016/j.radonc.2025.111047.
5
[Clinical efficacy of induction chemoimmunotherapy for locally advanced hypopharyngeal carcinoma: a prospective phase Ⅱ study].诱导化疗免疫疗法治疗局部晚期下咽癌的临床疗效：一项前瞻性Ⅱ期研究
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2024 Apr 7;59(4):350-356. doi: 10.3760/cma.j.cn115330-20240129-00056.
6
Induction chemotherapy for locally advanced nasopharyngeal carcinoma: Efficacy and safety of the TPC regimen compared to GP and TPF.局部晚期鼻咽癌的诱导化疗：TPC方案与GP和TPF方案相比的疗效与安全性
Oral Oncol. 2025 Jan;160:107119. doi: 10.1016/j.oraloncology.2024.107119. Epub 2024 Nov 25.
7
Gemcitabine and cisplatin versus docetaxel and cisplatin as induction chemotherapy followed by concurrent chemoradiotherapy in locoregionally advanced nasopharyngeal carcinoma from non-endemic area of China.吉西他滨和顺铂与多西他赛和顺铂作为诱导化疗，随后在非中国鼻咽癌高发地区进行同期放化疗治疗局部晚期鼻咽癌。
J Cancer Res Clin Oncol. 2020 Sep;146(9):2369-2378. doi: 10.1007/s00432-020-03229-3. Epub 2020 May 3.
8
Gemcitabine plus cisplatin versus docetaxel plus cisplatin and fluorouracil induction chemotherapy combined with locoregional radiotherapy in de novo metastatic nasopharyngeal carcinoma: A single center prospective phase II clinical trial.吉西他滨联合顺铂与多西他赛联合顺铂和氟尿嘧啶诱导化疗联合局部区域放疗治疗初治转移性鼻咽癌：一项单中心前瞻性 II 期临床试验。
Oral Oncol. 2024 Dec;159:107087. doi: 10.1016/j.oraloncology.2024.107087. Epub 2024 Nov 3.
9
Induction chemotherapy plus concomitant chemoradiotherapy in nasopharyngeal carcinoma: An updated network meta-analysis.诱导化疗联合同期放化疗治疗鼻咽癌：一项更新的网络荟萃分析。
Crit Rev Oncol Hematol. 2021 Apr;160:103244. doi: 10.1016/j.critrevonc.2021.103244. Epub 2021 Feb 11.
10
Comparison of GP and TPF induction chemotherapy for locally advanced nasopharyngeal carcinoma.GP 和 TPF 诱导化疗治疗局部晚期鼻咽癌的比较。
Oral Oncol. 2019 Oct;97:37-43. doi: 10.1016/j.oraloncology.2019.08.001. Epub 2019 Aug 8.
本文引用的文献
1
Induction chemotherapy for locally advanced nasopharyngeal carcinoma: Efficacy and safety of the TPC regimen compared to GP and TPF.局部晚期鼻咽癌的诱导化疗：TPC方案与GP和TPF方案相比的疗效与安全性
Oral Oncol. 2025 Jan;160:107119. doi: 10.1016/j.oraloncology.2024.107119. Epub 2024 Nov 25.
2
HAEMATOLOGICAL TOXICITIES OF GEMCITABINE PLUS CISPLATIN VERSUS FLUOROURACIL, CISPLATIN, PLUS DOCETAXEL FOLLOWED BY CONCURRENT CHEMORADIOTHERAPY IN LOCOREGIONALLY ADVANCED NASOPHARYNGEAL CARCINOMA.吉西他滨联合顺铂与氟尿嘧啶、顺铂联合多西他赛化疗序贯同期放化疗治疗局部进展期鼻咽癌的血液学毒性
J Ayub Med Coll Abbottabad. 2024 Jan-Mar;36(1):3-9. doi: 10.55519/JAMC-01-12489.
3
Gemcitabine plus cisplatin versus docetaxel plus cisplatin and fluorouracil induction chemotherapy combined with locoregional radiotherapy in de novo metastatic nasopharyngeal carcinoma: A single center prospective phase II clinical trial.吉西他滨联合顺铂与多西他赛联合顺铂和氟尿嘧啶诱导化疗联合局部区域放疗治疗初治转移性鼻咽癌：一项单中心前瞻性 II 期临床试验。
Oral Oncol. 2024 Dec;159:107087. doi: 10.1016/j.oraloncology.2024.107087. Epub 2024 Nov 3.
4
Gemcitabine/Cisplatin versus docetaxel, cisplatin and 5-fluorouracil as induction chemotherapy in locally advanced nasopharyngeal carcinoma.吉西他滨/顺铂与多西他赛、顺铂和5-氟尿嘧啶作为局部晚期鼻咽癌诱导化疗的比较
Am J Cancer Res. 2024 Sep 15;14(9):4506-4513. doi: 10.62347/YHUW1294. eCollection 2024.
5
Tislelizumab plus neoadjuvant chemotherapy and concurrent chemoradiotherapy versus neoadjuvant chemotherapy and concurrent chemoradiotherapy for locally advanced nasopharyngeal carcinoma: A retrospective study.替雷利珠单抗联合新辅助化疗及同步放化疗与新辅助化疗及同步放化疗治疗局部晚期鼻咽癌的回顾性研究
Transl Oncol. 2024 Oct;48:102058. doi: 10.1016/j.tranon.2024.102058. Epub 2024 Jul 30.
6
Nab-paclitaxel, cisplatin, and capecitabine versus cisplatin and gemcitabine as first line chemotherapy in patients with recurrent or metastatic nasopharyngeal carcinoma: randomised phase 3 clinical trial.奈达铂、顺铂和卡培他滨与顺铂和吉西他滨联合化疗治疗复发性或转移性鼻咽癌患者的一线治疗：随机 3 期临床试验。
BMJ. 2024 Jun 19;385:e077890. doi: 10.1136/bmj-2023-077890.
7
Induction-concurrent chemoradiotherapy with or without sintilimab in patients with locoregionally advanced nasopharyngeal carcinoma in China (CONTINUUM): a multicentre, open-label, parallel-group, randomised, controlled, phase 3 trial.中国局部晚期鼻咽癌患者同步诱导放化疗联合或不联合信迪利单抗（CONTINUUM）：一项多中心、开放标签、平行分组、随机、对照、III 期临床试验。
Lancet. 2024 Jun 22;403(10445):2720-2731. doi: 10.1016/S0140-6736(24)00594-4. Epub 2024 May 30.
8
Tumor molecular landscape of Epstein-Barr virus (EBV) related nasopharyngeal carcinoma in EBV-endemic and non-endemic areas: Implications for improving treatment modalities.爱泼斯坦-巴尔病毒（EBV）流行地区和非流行地区EBV相关鼻咽癌的肿瘤分子图谱：对改进治疗方式的启示
Transl Res. 2024 Mar;265:1-16. doi: 10.1016/j.trsl.2023.10.004. Epub 2023 Nov 8.
9
Final Overall Survival Analysis of Gemcitabine and Cisplatin Induction Chemotherapy in Nasopharyngeal Carcinoma: A Multicenter, Randomized Phase III Trial.吉西他滨和顺铂诱导化疗治疗鼻咽癌的最终总生存分析：一项多中心、随机 III 期试验。
J Clin Oncol. 2022 Aug 1;40(22):2420-2425. doi: 10.1200/JCO.22.00327. Epub 2022 Jun 16.
10
Meta-analysis of chemotherapy in nasopharynx carcinoma (MAC-NPC): An update on 26 trials and 7080 patients.鼻咽癌化疗的荟萃分析（MAC-NPC）：26项试验及7080例患者的最新情况
Clin Transl Radiat Oncol. 2021 Nov 26;32:59-68. doi: 10.1016/j.ctro.2021.11.007. eCollection 2022 Jan.
Zotero 插件